WhichRecall
Class IIReported 2025-11-05

Semaglutide Injection, 6mg/2.4mL (2.5 mg/mL), 2.4mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 84139-225-08

Recalled by ProRx LLC

Reason for Recall

Lack of Assurance of Sterility

Advertisement
Recall Number
D-0116-2026
Classification
Class II
Status
Ongoing
Category
drug
Initiated
2025-10-15
Reported
2025-11-05
Distribution
TX and UT
Code Info
Lot Prorx051425-2, Lot Prorx051425-3 and Lot Prorx051425-4
Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.
Advertisement